Background and Purpose-Carotid intima-media thickness (IMT) reflects generalized atherosclerosis and is predictive of future vascular events. Evidence exists that carotid IMT is heritable, and genetic studies can provide clues in the pathogenesis of atherosclerosis. Methods-We recruited 470 white ischemic stroke patients, measured common carotid artery (CCA) IMT, and analyzed 54 polymorphisms with suspected roles in atherosclerosis. Results-Among the polymorphisms tested, the angiotensin-converting enzyme insertion/deletion, osteopontin (OPN)
M
easuring carotid intima-media thickness (IMT) is a powerful technique for studying atherosclerosis. IMT is determined by visualizing the carotid arteries with highresolution ultrasound, then analyzing the images by computer to accurately measure the thickness. Increased carotid IMT is a marker of generalized atherosclerosis and is associated with future myocardial infarction and stroke. 1, 2 Familial epidemiological studies suggest that increased IMT is under genetic influence with heritability estimates of 30% to 40%. 3 There have been relatively few candidate gene studies, and further work is needed to identify genetic factors contributing to IMT. 4 Studying the genetics of IMT can help better understand the pathophysiology of atherosclerosis in stroke patients.
We sought to explore the genetics of carotid IMT in brain infarction (BI) patients from the GENétique de l'Infarctus Cérébral (GENIC) study. This analysis included all polymorphisms tested in the GENIC study. The genes all had potential roles in vascular pathology, including inflammation, hypertension, coagulation, and lipid metabolism (Table 1) , many of which had not been analyzed previously with IMT.
Methods Patients
Patients (nϭ510) were consecutively recruited from 12 different French neurological centers with the following criteria: (1) clinical symptoms of BI, (2) no hemorrhage on computed tomography, (3) BI proven by MRI, (4) 18 to 85 years of age, and (5) both parents of white origin. Patients were included within 1 week of the qualifying BI. All etiologic subtypes of BI were included for this analysis. Patients with a previous cardiovascular or cerebrovascular history were still eligible. There were 510 age-matched controls without BI, but they were not used for this analysis.
Data Collection and Risk Factor Definition
Demographic characteristics and risk factors were recorded with a questionnaire. Hypertension was defined as a previous history of hypertension treatment. Smoking was coded as never, previous, and current smoker. Subjects were classified as diabetic if treated previously for type 1 or type 2 diabetes mellitus. Use of lipidlowering drugs was assessed. A positive cardiovascular history was defined as past myocardial infarction, angioplasty, coronary artery bypass surgery, or lower-limb arterial disease. History of previous stroke or transient ischemic attacks was recorded.
Carotid Ultrasonography
All subjects underwent carotid ultrasound to measure carotid IMT and for the presence of plaques. Operators (who were all certified before the study) visualized the common carotid arteries (CCAs), and IMT was electronically measured on a segment without plaques. We also recorded internal carotid artery and carotid bifurcation for the purpose of plaque detection, but by protocol, we used only CCA-IMT measurements for this analysis. There was a much higher incidence of plaques at the carotid bifurcation and internal carotid 
Genotyping
One centralized laboratory performed DNA analysis from fasting morning blood samples. DNA was screened by polymerase chain reaction/SSCP for polymorphisms listed in Table 1 .
Statistical Analysis
Data analyses were based on 470 BI cases for whom a good-quality CCA-IMT measurement was available. All analyses were adjusted for age and gender. We studied the association between CCA-IMT and several risk factors using the analysis of covariance (ANCOVA).
The risk factors associated with CCA-IMT (PϽ0.05) were implemented in a stepwise multiple regression analysis with an entry and removal values set to 0.05. The risk factors that remained in the stepwise regression model were subsequently used to adjust the relationships between CCA-IMT and polymorphisms. We excluded the 29 polymorphisms with the less common allele frequency of Ͻ10% because there was very little power to detect significant associations (Table 1) . We compared the mean CCA-IMT between genotypes for the 54 remaining polymorphisms using ANCOVA adjusted for age and gender (ie, assuming no particular genetic model). The polymorphisms with a significant difference in mean CCA-IMT between genotypes were further explored in additive, dominant, and recessive genetic models using linear regression analysis. We used the Akaike Information Criterion (AIC) to select the best-fitting multivariate genetic model; the model with the lowest AIC score was the best fitting. Sensitivity analysis restricted to the 371 cases free of previous cardiovascular events was conducted using the best-fitting multivariate genetic model for the 3 identified polymorphisms. We performed haplotype analysis on the monocyte chemoattractant protein-1 (MCP-1) variants to better characterize their significant associations with CCA-IMT. These polymorphisms were in complete negative linkage disequilibrium (DЈ valueϭϪ1) and generated 6 combined genotypes and 3 haplotypes (AG, AC, and GG). We analyzed the relationship between CCA-IMT and haplotypes in the same manner as for the individual polymorphisms. The AC and GG haplotypes were each studied as biallelic polymorphisms by reference to AG-AG carriers and were entered together in genetic models. AC and GG were coded in no particular genetic model as 2 unordered variables (2 df), in additive genetic model as 2 ordered variables (1 df), in dominant genetic model as 2 dummy variables (contrasting the effect of heterozygotes and homozygotes to noncarriers), and in recessive genetic model as 2 dummy variables (contrasting the effect of homozygotes to heterozygotes and noncarriers). Because of the exploratory nature and the small sample size of this study, and because polymorphisms on the same gene were not independent, we did not adjust for multiple comparisons. However, acknowledging the contest of multiple testing, we used as statistical criteria value, a nominal P value cutoff of 0.01. Data were analyzed using the SAS package release 9.1 (SAS Institute). Table 2 shows the relationships between CCA-IMT and several characteristics in age-gender-adjusted analysis. Increased age, male gender, hypertension, higher total and low-density lipoprotein cholesterol, lower high-density lipoprotein cholesterol, higher blood pressure values, and cardiovascular history were associated with increased CCA-IMT (PϽ0.05). In stepwise multiple regression analysis, CCA-IMT remained associated with age (PϽ0.0001), male gender (PϽ0.0001), systolic blood pressure (Pϭ0.0005), low-density lipoprotein cholesterol (Pϭ0.022), and cardiovascular history (Pϭ0.013).
Results
Of the 54 polymorphisms tested, there were significant differences in CCA-IMT between the genotypes of osteopontin (OPN) T-443C, MCP-1 G-927C and MCP-1 A-2578G (referred to as A-2518G in other reports; Figure) . We also noted a small trend toward a higher mean CCA-IMT for homozygotes of angiotensin-converting enzyme deletion (ACE D; age-gender-adjusted meanϮSE; 0.814Ϯ0.011) compared with carriers of ACE insertion (ACE I; agegender-adjusted meanϮSE; 0.787Ϯ0.008; Pϭ0.044). In addition, there was no correlation between plasma ACE and CCA-IMT (Pearson coefficient correlation 0.06; Pϭ0.17).
OPN T-443C Polymorphism
Patients with the TT genotype had lower mean CCA-IMT compared with C allele carriers (Figure) . The -443C allele effect for increased IMT was significant in additive and dominant genetic models with a lowest AIC score for the dominant genetic model ( Table 3 ). The adjusted meanϮSE of CCA-IMT was 0.757Ϯ0.014 in carriers of TT genotype and 0.817Ϯ0.008 in carriers of TC or CC genotypes. The C allele dominant effect remained significant in sensitivity analysis restricted to incident cases without previous cardiovascular history (adjusted regression coefficient 0.048; Pϭ0.004). The P values were computed using ANCOVA adjusted for age and sex. Adjusted Pearson correlation coefficients and adjusted means of CCA-IMT are shown.
LDL indicates low-density lipoprotein; HDL, high-density lipoprotein.
MCP-1 Polymorphisms
As shown in the Figure, 
Discussion
After adjusting for appropriate covariates, there were significant associations with CCA-IMT and 2 genes: OPN and MCP-1. Interestingly, these are both proinflammatory cytokines with important roles in atherosclerosis by directing leukocytes to vascular endothelium. 5, 6 There is little previous knowledge how these polymorphisms affect atherosclerotic phenotypes.
Monocyte Chemoattractant Protein-1
These results suggest associations of the MCP-1-927C and -2578A alleles with increased CCA-IMT. The alleles were significant in multivariate recessive genetic models (PϽ0.005). These variants reside in the promoter region of the MCP-1 gene and could potentially affect MCP-1 transcription and expression. The 2 polymorphisms were in complete linkage disequilibrium, so the actual disease-causing locus could reside nearby. In haplotype analysis, AC was associated with the thickest and CG with the thinnest IMT in recessive model (PϽ0.009). The haplotype analysis did not improve the strength of the association.
MCP-1 is a powerful attractant of monocytes and T cells with well-known roles in atherosclerosis. MCP-1 is synthesized by multiple cells involved in atherosclerosis, including endothelial cells, smooth muscle cells, fibroblasts, and mac- The regression coefficients (␤) were computed using linear regression adjusted for age, gender, systolic blood pressure, low-density lipoprotein cholesterol and cardiovascular history.
rophages. 7 In the early stages of atherogenesis, MCP-1 is the primary chemokine recruiting monocytes into the arterial subendothelium. 8 MCP-1 protein and mRNA are highly expressed in atherosclerotic vessels but not normal vessels. 7,9 -12 In addition, a study demonstrated that mice lacking MCP-1 have attenuated atherogenesis and arterial monocyte accumulation. 13 There have been very few reports of MCP-1 A-2578G in atherosclerosis 10,14 -16 and none on G-927C. Tabara et al found no association of A-2578G with carotid IMT in a Japanese patients. 15 Alonso-Villaverde reported that -2578G was associated with increased progression of carotid IMT in HIV-infected patients, 10 and Szalai found that -2578G was associated with presence of severe coronary artery disease. 14 Although we observed a protective effect of the G allele on IMT, this discrepancy could be explained by different patient populations, by chance, or inadequate sample sizes. In addition, A-2578G could be protective or harmful depending on the disease state. 17 
Osteopontin
There was a strong association of the OPN-443C allele with increased IMT in dominant model remaining significant in multivariate analysis (PϽ0.001). The polymorphism resides in the promoter region of the OPN gene and is a common variant because allelic frequencies are roughly equal in the general population. The OPN T-443C polymorphism is in a binding site for the MYT1 zinc finger, but it is currently unknown how it affects OPN transcription or plasma levels. 18 This polymorphism is relatively unstudied in atherosclerosis.
OPN is a multifunctional protein expressed by many cell types, with roles in atherosclerosis, cell-mediated immunity, and macrophage recruitment and activation. 19 In early stages of atherosclerosis, OPN attracts inflammatory cells, promotes the release of proteinolytic enzymes, and stimulates smooth muscle cell proliferation. 20 -22 Plasma OPN is increased in severe coronary artery disease, 23 and there are high concentrations of OPN in the intima from carotid endarterectomy specimens. 24 In later stages of atherosclerosis, macrophages synthesize OPN at high levels, which may limit further calcification. 25 
ACE I/D
The ACE D allele was not significantly associated with higher IMT after adjusting for age and sex. Although ACE D was strongly associated with elevated plasma ACE (Pϭ0.001), 26 there was no correlation between plasma ACE and IMT. Therefore, we cannot confirm a positive association between the ACE D allele and increased IMT, as described in some other reports. 27 Future studies of ACE I/D should include plasma ACE measurements.
Although measuring IMT was part of the original design of the GENIC study and the genes were prespecified, there were several limitations to this analysis. This study included only white ischemic BI patients, and there could be different results in other populations. The GENIC controls were not included in the analysis or a replication study because they were age-and location-matched selected inpatients, and including them could risk selection bias. In addition, the GENIC controls were admitted with various non-neurological diseases and were therefore a heterogenous group with different vascular risk factors. The main limitation of the present study is the lack of adequate statistical power to detect associations, especially when testing 54 polymorphisms. Therefore, we could not consider gene-gene and gene-environment interactions. Because of the exploratory nature and the small sample size of the present study and because polymorphisms on the same gene are not independent, we did not adjust for multiple testing. Even if we used a more stringent criteria for declaring statistical significance, we caution that we could not exclude the possibility that the positive findings were attributable to chance. For these reasons, the present results should be considered hypothesis generating and be replicated in further larger studies, preferably from a community prospective population.
Conclusion
In this exploratory study, there were strong associations with the MCP-1 and OPN genes and CCA-IMT in these patients. These genes have important roles in atherosclerosis, and it has been suggested that blockade of both molecules could synergistically inhibit atherosclerosis. 25 We did not measure transcriptional activity or protein concentrations, and these results should be replicated in further large population-based studies.
